DXSP DXS International Plc

 
TIDMDXSP 
 

DXS INTERNATIONAL PLC

RESULT OF ANNUAL GENERAL MEETNG

("DXSP")

The Board of DXS International plc ("the Company"), the AQSE Growth Market quoted healthcare information and digital clinical decision support systems provider, is pleased to announce that the Annual General Meeting of the Company was held on Thursday 1 December 2022.

All resolutions as set out in the Notice of Meeting dated 4 November 2022 were passed and copies of the Resolutions are available on the Company's website

The Directors of DXS International plc accept responsibility for this announcement.

Contacts:

 
David Immelman (Chief Executive)            01252 719800 
 DXS International plc             david@dxs-systems.com 
https://www.dxs-systems.co.uk 
 
 
Corporate Advisor 
City & Merchant 
 David Papworth     020 7101 7676 
 
 
Corporate Broker 
Hybridan LLP 
 Claire Louise Noyce   020 3764 2341 
 

Notes to Editors

About DXS:

DXS International presents up to date treatment guidelines and recommendations, from Clinical Commissioning Groups and other trusted NHS sources, to doctors, nurses and pharmacists in their workflow and during the patient consultation. This effective clinical decision support ultimately translates to improved healthcare outcomes delivered more cost effectively and which should significantly contribute towards the NHS achieving its projected efficiency savings.

(END) Dow Jones Newswires

December 02, 2022 10:30 ET (15:30 GMT)

DXS (AQSE:DXSP)
Historical Stock Chart
From Jan 2025 to Feb 2025

DXS (AQSE:DXSP)
Historical Stock Chart
From Feb 2024 to Feb 2025